NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-141-2019-0-US-07 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME US National Stage 18/009,571 Pending
NIAID E-104-2020-0-EP-06 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS EP National Stage 21729760.5 Pending
NIAAA E-190-2021-0-EP-01 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds EP National Stage
NIAAA E-190-2021-0-IL-01 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds IL National Stage
NIAAA E-190-2021-0-PCT-02 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds PCT PCT PCT/US2022/081131 Pending
NIAAA E-190-2021-0-US-02 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds US National Stage
NEI E-071-2020-0-AU-04 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME AU National Stage 2021300425 Pending
NCI E-082-2023-0-EP-01 LIGANDS SPECIFIC FOR ASCT1 EP ORD 22306795.0 Pending
NIDA E-183-2021-0-US-02 PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION US ORD 18/076,071 Pending
NCATS E-169-2019-0-US-03 DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS US National Stage 18/000,653 Pending
NIAID E-080-2013-0-AU-10 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization AU DIV 2022279509 Pending
NIAID E-060-2015-0-AU-20 Novel Multivalent Nanoparticle-Based Vaccines AU DIV 2022279441 Pending
NCI E-219-2021-0-PCT-02 Identification Of And Cloning SBTCR_m807, A T Cell Receptor Targeting Kras G12V Mutation On HLA-A0301+ PCT PCT PCT/US2022/080650 Pending
NCI E-199-2021-0-PCT-02 COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF PCT PCT PCT/US2022/051249 Pending
NCI E-062-2019-3-US-01 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US CON 18/059,840 Abandoned
NCI E-265-2015-0-JP-36 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` JP DIV 2022-188263 Pending
NICHD E-039-2015-0-US-20 ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF US CON 18/058,457 Pending
NEI E-165-2017-0-US-05 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES US DIV 18/058,064 Pending
NIAID E-228-2016-1-JP-16 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof JP DIV 2022-186724 Pending
NCI E-173-2018-2-JP-01 Viral Methods Of T Cell Therapy JP DIV 2022-185536 Pending
NIAID E-052-2017-4-MX-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MX DIV MX/a/2022/014631 Pending
NCI E-059-2013-0-JP-25 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP DIV 2022-185113 Pending
NIAID E-238-2020-0-PCT-02 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) PCT PCT PCT/US2022/080015 Pending
NHGRI E-275-2015-0-US-05 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC US DIV 18/056,356 Pending
NIAID E-238-2020-0-US-03 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) US CON
NIAID E-128-2021-0-EP-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS EP National Stage 21803062.5 Pending
Leidos E-184-2020-0-US-03 TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS US National Stage 17/925,582 Pending
NLM E-125-2017-2-US-06 CRYSTAL STRUCTURE OF CRISPR CPF1 US CON 17/986,277 Pending
NIAID E-064-2016-1-CN-10 RSV F IMMUNOGENS AND THEIR USE CN DIV 202211420259.2 Pending
NCATS E-101-2017-0-EP-07 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS EP DIV 22207287.8 Pending
NIAID E-128-2021-0-US-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS US National Stage 17/998,752 Pending
NIAID E-171-2021-0-PCT-02 SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN PCT PCT PCT/US2022/079750 Pending
NIAID E-104-2020-0-US-08 RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS US National Stage 17/924,784 Pending
NICHD E-151-2021-0-PCT-02 NUCLEAR MAGNETIC RESONANCE METHODS OF DETERMINING HOMEOSTATIC
PERTURBATIONS 		PCT PCT PCT/US2022/049542 Pending
NCI E-205-2021-0-PCT-02 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF PCT PCT PCT/US2022/079554 Pending
NEI E-058-2018-0-US-08 Using Machine Learning And/or Neural Networks To Validate Stem Cells And Their Derivatives (2-D Cells And 3-D Tissues) Fro Use In Cell Therapy And Tissue Engineered Products US CON 17/983,963 Pending
NIAID E-095-2021-0-PCT-02 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2022/079340 Expired
NHGRI E-054-2020-0-US-03 ABERRANT POST-TRANSLATIONAL MODIFICATIONS(PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS US National Stage 17/923,394 Pending
NCI E-099-2014-0-JP-01 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2022-177351 Pending
NCATS E-004-2016-0-CN-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CN DIV 202211334125.9 Pending
NIDCR E-150-2019-0-US-03 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear US National Stage 17/922,300 Pending
NCATS E-043-2017-3-US-01 Pharmaceutical Compositions With Antiflaviviral Activity US CON 18/050,177 Pending
NICHD E-200-2021-0-PCT-02 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE PCT PCT PCT/US2022/078713 Expired
NICHD E-200-2021-0-EP-01 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE EP National Stage Pending
NCI E-204-2021-0-PCT-02 SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN PCT PCT PCT/US2022/078632 Expired
NCI E-104-2013-0-US-06 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 18/049,470 Pending
NCI E-135-2019-0-HK-17 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 HK EP 62022062662.1 Pending
NIAID E-097-2020-0-KR-09 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE KR National Stage 10-2022-7037236 Pending
NICHD E-072-2017-0-JP-08 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE JP DIV 2022-169032 Issued
NIAID E-297-2016-2-AU-11 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU DIV 2022256195 Pending